A naukri.com initiative
Bioengineer
6d
173
Image Credit: Bioengineer
Researchers Harness Gene Editing to Repair Harmful Mitochondrial Mutations in Human Cells
- In a groundbreaking advancement, scientists have used mitochondrial base editing to correct harmful mutations in human cells, as detailed in PLOS Biology on June 24.
- Mitochondrial DNA mutations are challenging to address due to unique properties, but this new editing tool offers therapeutic potential for mitochondrial diseases.
- By employing a specialized mitochondrial base editor, researchers successfully corrected mutations in liver and skin cells, restoring mitochondrial function.
- Delivery of gene editing components using mRNA in lipid nanoparticles enhanced efficiency and safety of the process.
- The editing process showed high specificity with minimal off-target effects, highlighting the precision of mitochondrial base editing.
- This advancement could revolutionize clinical approaches to mitochondrial disorders, offering potential cures rather than just symptomatic management.
- While challenges like in vivo delivery and long-term effects exist, the ability to edit mitochondrial DNA represents a significant leap in genetic medicine.
- The study signifies a transformative era in mitochondrial medicine, paving the way for genetic therapies targeting root causes of diseases.
- Mitochondrial base editing via lipid nanoparticles and mRNA holds promise for precision mitochondrial DNA editing with wide-ranging implications in genetic disease treatment.
- Continued research in this field can unlock further innovations in precision medicine, offering new interventions for genetic diseases.
- This discovery showcases the potential of genetic engineering to reshape the landscape of disease treatment, bridging gaps in mitochondrial genetics.
Read Full Article
10 Likes
For uninterrupted reading, download the app